• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AGN

ARGENICA THERAPEUTICS LIMITED

19.3% ! 26.3¢
Market Cap $28.26M  !

Argenica Therapeutics Limited is an Australia-based biotechnology company, developing... Argenica Therapeutics Limited is an Australia-based biotechnology company, developing novel therapeutics to reduce brain tissue death after stroke and other types of brain injury and neurodegenerative diseases to improve patient outcomes. The Company's lead neuroprotective peptide candidate, ARG-007, has been demonstrated to improve outcomes in pre-clinical stroke models, traumatic brain injury (TBI) and hypoxic ischemic encephalopathy (HIE). The Company has completed a Phase I clinical trial in healthy human volunteers to assess the safety and tolerability of a single dose of ARG-007. It has completed dosing in a Phase II clinical trial in ischaemic stroke patients and continues to generate preclinical data in other neurological conditions, including in TBI and HIE.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
AGN
News, Articles and interviews
04/12/25 17 2.4K
04/12/25 Last post  Scottsmyname Comments Created with Sketch.  17  Views Created with Sketch.  2.4K 
AGN 04/12/25 10 1.5K
04/12/25 Last post  Scottsmyname Comments Created with Sketch.  10  Views Created with Sketch.  1.5K 
AGN
AGN Media thread
8 9 10
02/12/25 556 169K
02/12/25 Last post  MrLearner Comments Created with Sketch.  556  Views Created with Sketch.  169K 
AGN
Strokes - old age
30/11/25 0 116
30/11/25 Last post  Scottsmyname Comments Created with Sketch.  0  Views Created with Sketch.  116 
AGN
AGN share price/chart
30/11/25 7 1.9K
30/11/25 Last post  Scottsmyname Comments Created with Sketch.  7  Views Created with Sketch.  1.9K 
AGN 26/11/25 5 1.1K
26/11/25 Last post  hotcoughper Comments Created with Sketch.  5  Views Created with Sketch.  1.1K 
AGN 12/11/25 0 217
12/11/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  217 
AGN 12/11/25 0 169
12/11/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  169 

See All Discussions arrow Created with Sketch.

Timeline

Positive TNK Study Results Fulfil Key FDA Requirement
04 Dec 08:17
 
ARG-007 Efficacious Dose Validated in New Preclinical Study
25 Nov 09:16
 
Final Director's Interest Notice
12 Nov 19:05
 
Results of Annual General Meeting
12 Nov 19:03
 
AGM Chair's Address & Presentation
12 Nov 16:53
 
Non-Executive Director Retirement
12 Nov 16:49
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
26.3¢
Change
0.043(19.3%)
Mkt cap ! $28.26M
Open High Low Volume
24.0¢ 29.5¢ 24.0¢ 1.120M

Buyers (Bids)

Vol. Price($)
86848 26.0¢
 

Sellers (Offers)

Price($) Vol.
27.0¢ 19999
Last trade - 16.10pm 04/12/2025 (20 minute delay) ?
AGN (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.